Univest Securities, LLC Announces Closing of $1.2 Million Registered Direct Offering for its Client Focus Universal Inc. (NASDAQ: FCUV)
September 17, 2024 18:00 ET
|
Univest Securities, LLC
New York, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York,...
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
September 13, 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO
September 09, 2024 08:30 ET
|
Quoin Pharmaceuticals, Inc.
ASHBURN, Va., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals (NASDAQ: QNRX), a clinical stage, specialty pharmaceutical company focused on developing and commercializing novel treatments...
Aclarion Added to PRISM Emerging Medical Devices Index
September 06, 2024 11:27 ET
|
PRISM MarketView
Aclarion Added to PRISM Emerging Medical Devices Index
Nasdaq Announces New Leadership and Structure for Financial Crime Management Technology
September 06, 2024 07:00 ET
|
Nasdaq, Inc.
Appoints 13-year Nasdaq Verafin Veteran, Stephanie Champion, as New Head of Nasdaq Verafin Nasdaq Chief Strategy Officer, Jeremy Skule, to Take on Expanded Role as Executive Chair of Nasdaq’s...
Calvetti Ferguson Partner Elected Treasurer of ACG Houston Board
August 27, 2024 08:00 ET
|
Calvetti Ferguson
Calvetti Ferguson partner, Anneka Sciola, is elected treasurer of the ACG Houston Board.
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
August 20, 2024 09:00 ET
|
PRISM MarketView
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
Nephros Announces Financial Results for Quarter Ended June 30, 2024
August 08, 2024 16:01 ET
|
Nephros, Inc.
Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a...
Oncocyte Announces August Investor Conferences Participation
August 05, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Announces August Investor Conferences Participation
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
August 05, 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024